Global Healthcare Market and Growth Strategy slide image

Global Healthcare Market and Growth Strategy

The Clinical Research Industry In a highly competitive climate, pharma companies want to see trial data in real time to allow faster decision-making and planning for later stage trials Pharma struggles to access real-world data from the health system Companies must also contract third-parties for secure capture, storage and smart structuring of data Data Needs 80% of clinical research participants indicated that they were unwilling to visit the trial site for study appointments Identifying patients for clinical trials is extremely difficult and costly Subject Demands Trial delays are a key driver of costs Companies have begun implementing digital tools due to COVID-19 which will save costs in a post-pandemic world The FDA and Health Canada have released guidance for real-world evidence, encouraging the use of technology Regulatory Change BioPharma SERVICES INC. $ Healthcare Delivery Digitizing Rising Costs | Clinical research industry is I at a tipping point where digitization will become essential and conversion to SaaS will set first-movers apart. thinkresearch TSXV: THNK 14
View entire presentation